Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -35.184% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) CCOC(=O)CNC(=S)N(CCCN1CCN(C)CC1)Cc1cccs1
b) Cc1ccccc1Oc1nc(-c2ccccn2)nc2ccccc12
c) C[C@H]1C(=O)O[C@@H]2CCN3CC=C(COC(=O)[C@](C)(O)[C@]1(C)O)[C@H]23
d) Cc1ccc(S(=O)(=O)N2CCOCC2)cc1C(=O)Nc1ccncc1
e) O=C(CCc1ccccc1)NNC(=O)COc1ccccc1Cl
Answer: d. Cc1ccc(S(=O)(=O)N2CCOCC2)cc1C(=O)Nc1ccncc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)N2CCOCC2)cc1C(=O)Nc1ccncc1
Cc1ccc(S(=O)(=O)N2CCOCC2)cc1C(=O)Nc1ccncc1
2-methyl-5-morpholin-4-ylsulfonyl-N-pyridin-4-ylbenzamide